Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

86 trials with published results (11%)

Research Maturity

524 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.6%

20 terminated out of 767 trials

Success Rate

96.3%

+9.7% vs benchmark

Late-Stage Pipeline

2%

15 trials in Phase 3/4

Results Transparency

16%

86 of 524 completed with results

Key Signals

86 with results96% success20 terminated

Data Visualizations

Phase Distribution

730Total
Not Applicable (155)
Early P 1 (11)
P 1 (537)
P 2 (12)
P 3 (6)
P 4 (9)

Trial Status

Completed524
Recruiting111
Not Yet Recruiting42
Active Not Recruiting29
Terminated20
Unknown15

Trial Success Rate

96.3%

Benchmark: 86.6%

Based on 524 completed trials

Clinical Trials (767)

Showing 20 of 20 trials
NCT07671833Phase 1CompletedPrimary

A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects

NCT07545226Phase 1CompletedPrimary

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.

NCT07828197Phase 1Active Not Recruiting

A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites

NCT07852325Phase 1CompletedPrimary

Comparative Pharmacokinetics of SHR-8068 and Ipilimumab in Healthy Chinese Men

NCT07219719Phase 1RecruitingPrimary

Temporal Interference for Thalamocortical Activity and Network Modulation

NCT07746817Phase 1Recruiting

A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

NCT07847697Phase 1Not Yet RecruitingPrimary

A Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, PK/PD Characteristics, and Efficacy of SCTB10

NCT07848048Not ApplicableCompletedPrimary

Acute Musculoskeletal Responses to Blood Flow Restriction Training

NCT07723118Phase 1CompletedPrimary

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent

NCT07546201Not Yet Recruiting

Investigation of Imagery Abilities in Individuals With Migraine

NCT07844954Phase 1Not Yet RecruitingPrimary

Safety, Tolerability, and Pharmacokinetics of DM1001 Transdermal Patch in Healthy Chinese Participants

NCT06809608Phase 1CompletedPrimary

A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081

NCT07622433Phase 1CompletedPrimary

A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults

NCT07843368Phase 1Not Yet RecruitingPrimary

Safety, Tolerability, PK, and PD of TGM-148 in Healthy Participants

NCT07224074Phase 1CompletedPrimary

Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)

NCT06951880Phase 1RecruitingPrimary

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

NCT07837661Not ApplicableCompletedPrimary

Prefrontal Hemodynamics and Working Memory After Exhaustive Aquatic Exercise

NCT07780383Phase 1Recruiting

A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration

NCT07840066Not ApplicableActive Not RecruitingPrimary

Probiotics in Wellbeing

NCT07035769Phase 1RecruitingPrimary

A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

Scroll to load more

Research Network

Activity Timeline